Orchid Pharma Limited announced the merger with Dhanuka Laboratories Limited is now legally effective as of July 10, 2026. The companies filed the NCLT order with the Registrar of Companies, finalizing the amalgamation.
Orchid Pharma Completes Merger with Dhanuka Laboratories
Orchid Pharma Limited's merger with Dhanuka Laboratories Limited is now legally effective as of July 10, 2026. The companies have filed the certified copy of the National Company Law Tribunal (NCLT) Order with the Registrar of Companies, Chennai, marking the completion of the amalgamation process.
Reader Takeaway: Merger legally finalized; focus shifts to operational integration and synergy realization.
What just happened
The Scheme of Amalgamation between Orchid Pharma Limited and Dhanuka Laboratories Limited has become effective. Dhanuka Laboratories Limited has been dissolved without winding up, integrating its operations into Orchid Pharma Limited.
Why this matters
This legal completion signifies the end of the merger process. Investors can now expect Orchid Pharma to focus on operational consolidation and achieving business synergies from the combined entity. The financial reporting will align with the scheme, with an Appointed Date of April 01, 2024.
The backstory
The merger process involved NCLT approval, followed by the filing of the certified order with the Registrar of Companies. The Appointed Date for the merger was April 01, 2024, and the Effective Date is July 10, 2026.
What changes now
Dhanuka Laboratories Limited ceases to exist as a separate legal entity. Orchid Pharma Limited will operate as the consolidated company. Future disclosures will likely detail the progress of operational integration and any resulting financial impacts.
Risks to watch
Potential risks include challenges in integrating operations, achieving expected synergies, and any unforeseen financial impacts during the consolidation phase. Investors should monitor future announcements for clarity on these aspects.
Peer comparison
(No peer comparison data available in the filing).
Context metrics (time-bound)
- Appointed Date: April 01, 2024
- Effective Date: July 10, 2026
What to track next
Investors should closely watch for updates on post-merger operational integration, synergy realization, and the financial performance of the consolidated Orchid Pharma Limited.